Suscribirse

Reducing severe maternal morbidity for birthing persons with severe hypertension through a statewide quality improvement initiative - 24/12/24

Doi : 10.1016/j.ajog.2024.04.026 
Ann Borders, MD, MSc, MPH a, b, c, , Lauren Keenan-Devlin, PhD, MPH a, Elissa H. Oh, MA b, c, Danielle Young, MPH b, c, William Grobman, MD, MBA b, c, d, Patricia Lee King, PhD, MSW a, b, c
a NorthShore University HealthSystem, Evanston, IL 
b Pritzker School of Medicine, University of Chicago, Chicago, IL 
c Feinberg School of Medicine, Northwestern University, Chicago, IL 
d Wexner Medical Center, The Ohio State University, Columbus, OH 

Corresponding author: Ann Borders, MD, MSc, MPH.

Abstract

Background

Hypertensive disorders of pregnancy are a leading preventable cause of severe maternal morbidity and maternal mortality worldwide.

Objective

To assess the improvement in hospital care processes and patient outcomes associated with hypertensive disorders of pregnancy after introduction of a statewide Severe Maternal Hypertension Quality Improvement Initiative.

Study Design

A prospective cohort design comparing outcomes before and after introduction of the Illinois Perinatal Quality Collaborative statewide hypertension quality improvement initiative among 108 hospitals across Illinois. Participating hospitals recorded data for all cases of new-onset severe hypertension (>160 mm Hg systolic or >110 mm Hg diastolic) during pregnancy through 6 weeks postpartum from May 2016 to December 2017. Introduction of the statewide quality improvement initiative included implementation of severe maternal hypertension protocols, standardized patient education and discharge planning, rapid access to medications and standardized treatment order sets, and provider and nurse education. The main outcome measure was the reduction of severe maternal morbidity for pregnant/postpartum patients with severe hypertension. Key process measures include time to treatment of severe hypertension, frequency of provider/nurse debriefs, appropriate patient education, and early postpartum follow-up.

Results

Data were reported for 8073 cases of severe maternal hypertension. The frequency of patients with new-onset severe hypertension treated within 60 minutes increased from 41% baseline to 87% (P<.001) at the end of the initiative. The initiative was associated with increased proportion of patients receiving preeclampsia education at discharge (41% to 89%; P<.001), scheduling follow-up appointments within 10 days of discharge (68% to 83%; P<.001), and having a care team debrief after severe hypertension was diagnosed (17% to 59%; P<.001). Conversely, severe maternal morbidity was reduced from 11.5% baseline to 8.4% (P<.002) at the end of the study period. Illinois hospitals have achieved time to treatment goal regardless of hospital characteristics including geography, birth volume, and patient mix.

Conclusion

Introduction of a statewide quality improvement effort was associated with improved time to treatment of severe hypertension and increased frequency of provider/nurse debriefs, appropriate patient education, and early postpartum follow-up scheduled at discharge, and reduced severe maternal morbidity.

El texto completo de este artículo está disponible en PDF.

Video


(8.2 Mo)

El texto completo de este artículo está disponible en PDF.

Key words : early postpartum follow-up, Illinois Perinatal Quality Collaborative, improvement science, patient education, perinatal quality, preeclampsia, preeclampsia education, quality improvement, team debrief, time to treatment


Esquema


 The authors report no conflict of interest.
 An earlier version of this study, “Reducing time to treatment for severe maternal HTN through statewide quality improvement,” was presented at the Society for Maternal-Fetal Medicine 38th Annual Meeting, Dallas, TX, from January 29 through February 3, 2018.
 This study was funded by the Centers for Disease Control and Prevention, the Illinois Department of Public Health, and the Alliance for Innovation on Maternal Health.
 Cite this article as: Borders A, Keenan-Devlin L, Oh EH, et al. Reducing severe maternal morbidity for birthing persons with severe hypertension through a statewide quality improvement initiative. Am J Obstet Gynecol 2025;232:128.e1-9.


© 2024  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 232 - N° 1

P. 128.e1-128.e9 - janvier 2025 Regresar al número
Artículo precedente Artículo precedente
  • Lasix for the prevention of de novo postpartum hypertension: a randomized placebo-controlled trial (LAPP Trial)
  • Ukachi N. Emeruwa, Hooman Azad, Samsiya Ona, Shai Bejerano, Sarah Alnafisee, Jordan Emont, Sharon Mathew, Michelle Batlle, Denice Arnold, Erinma P. Ukoha, Louise C. Laurent, Marni Jacobs, Janice J. Aubey, Russell S. Miller, Cynthia Gyamfi-Bannerman
| Artículo siguiente Artículo siguiente
  • Implementation of perinatal quality collaborative statewide initiative improves obstetrical opioid use disorder care and outcomes
  • Patricia A. Lee King, SuYeon Lee, Dan Weiss, David Aaby, Tamela Milan-Alexander, Ann E.B. Borders

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.